2010 NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: Measures of Structural Change and Visual Function

The National Eye Institute (NEI) and the Food and Drug Administration (FDA) invite you to help develop definitions and standards to describe structural changes in the glaucomatous optic nerve and functional changes in vision that could constitute "approvable" endpoints for new glaucoma therapeutics.
Source: News from NEI - Category: Opthalmology Tags: News and Events Source Type: news